Mackenzie Financial’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,417
Closed -$212K 1605
2025
Q4
$212K Buy
+3,417
New +$195K ﹤0.01% 1522
2022
Q3
Sell
-3,718
Closed -$232K 1487
2022
Q2
$232K Buy
3,718
+676
+22% +$47.9K ﹤0.01% 1222
2022
Q1
$249K Buy
3,042
+151
+5% +$11.7K ﹤0.01% 1204
2021
Q4
$253K Sell
2,891
-200
-6% -$16.7K ﹤0.01% 1231
2021
Q3
$245K Buy
+3,091
New +$254K ﹤0.01% 1226
2019
Q1
Sell
-5,350
Closed -$489K 1281
2018
Q4
$489K Buy
+5,350
New +$575K ﹤0.01% 939
2017
Q2
Sell
-5,400
Closed -$265K 647
2017
Q1
$265K Hold
5,400
﹤0.01% 577
2016
Q4
$243K Buy
+5,400
New +$265K ﹤0.01% 583

Other funds holding LIVN

Mackenzie Financial's LIVN Position: Q1 2026 in Review

Mackenzie Financial sold out of LivaNova (LIVN) in Q1 2026, closing a stake of 3,417 shares — an estimated $212K sold.

Mackenzie Financial first reported a position in LIVN in Q4 2016 and held it in 8 quarters. The position peaked at $489K in Q4 2018. 292 funds tracked by Wall St. Rank hold LIVN as of Q1 2026.

  • Mackenzie Financial reported no remaining LivaNova position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 3,417 LivaNova shares in Q1 2026, an estimated $212K.
  • Mackenzie Financial first reported a position in LivaNova in Q4 2016 and held it in 8 quarters.
  • Mackenzie Financial's LivaNova position peaked at $489K in Q4 2018.
  • 292 funds tracked by Wall St. Rank held LivaNova as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.